Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-03-31Clinical Trial Update: Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia [NA]
This completed clinical trial evaluated blood gene expression signatures in patients diagnosed with probable Alzheimer's disease to distingu…
-
FDA approval · 2011-03-29FDA Approved: GALANTAMINE — Original Application (Aurobindo Pharma Limited)
FDA approves the Original Application (ANDA) for Galantamine submitted by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease [Phase 4]
Phase 4 trial assessing the convenience, tolerability, and safety of switching Alzheimer's patients from rivastigmine capsules to a transder…
-
CLINICAL_TRIALS research · 2011-03-24Clinical Trial Update: A Study of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test
This is a clinical trial update describing a study of Alzheimer's disease using magnetoencephalography (MEG) and the Synchronous Neural Inte…
-
CLINICAL_TRIALS trial_result · 2011-03-15Clinical Trial Update: An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease [Phase 1]
A Phase 1 escalating-dose study evaluated safety, tolerability, and pharmacokinetics of LNK 754 in elderly volunteers and individuals with m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-03-15Clinical Trial Update: Alzheimer's Disease and Related Disorders
Clinical trial update related to Alzheimer's disease and related disorders. The sponsor is University Hospital, Angers, with conditions list…
-
CLINICAL_TRIALS research · 2011-03-14Clinical Trial Update: Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)
Ongoing clinical trial update from University Hospital Angers assessing adherence to and effects of balance exercises in individuals with Al…
-
CLINICAL_TRIALS trial_result · 2011-03-11Clinical Trial Update: Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease [Phase 4]
Phase 4 trial results evaluating the clinical effectiveness of a 10 cm^2 rivastigmine transdermal patch in Alzheimer's disease have been rep…
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: Treatment of Apathy in Alzheimer's Disease With Modafinil [Phase 3]
Phase 3 trial evaluating modafinil for apathy in Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED) [Phase 1]
Completed Phase 1 trial evaluating the performance of the CogState Computerized Neuropsychological Battery in patients with Alzheimer's dise…
-
CLINICAL_TRIALS research · 2011-02-17Clinical Trial Update: AIDMA: A Psycho-educational Program Designed to Support and Train Carers of Alzheimer's Disease (AD) Patients [NA]
This clinical trial update notes the completion of a study evaluating AIDMA, a psycho-educational program designed to support and train care…
-
CLINICAL_TRIALS trial_result · 2011-02-16Clinical Trial Update: Pharmacokinetic Comparisons of Two Donepezil Formulations [Phase 1]
A Phase 1 study comparing the pharmacokinetic profiles of two donepezil formulations in Alzheimer's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2011-02-15Clinical Trial Update: Alzheimer's Disease Reminiscence Quality of Life [Phase 4]
A Phase 4 study evaluating reminiscence-based quality of life in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid
Completed clinical trial assessing the effect of Aricept on cerebrospinal fluid biomarkers (acetylcholine and sAPP alpha) in Alzheimer's dis…
-
CLINICAL_TRIALS trial_result · 2011-02-08Clinical Trial Update: The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil [EARLY_Phase 1]
This completed early Phase 1 trial evaluated changes in cognitive function after 12 weeks of donepezil treatment in individuals with Alzheim…
-
CLINICAL_TRIALS research · 2011-02-07Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163 [Phase 1]
This document summarizes a Phase 1 study evaluating the pharmacokinetics, safety, and tolerability of BMS-708163 in Alzheimer's disease. The…
-
FDA approval · 2011-02-02FDA Approved: GALANTAMINE HYDROBROMIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original ANDA for galantamine hydrobromide, a generic version of galantamine indicated for mild …
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease [Phase 3]
Phase 3 trial comparing risperidone with placebo for psychotic symptoms in Alzheimer's disease. The study evaluated efficacy and safety in t…
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating the long-term safety and efficacy of galantamine in Alzheime…
-
CLINICAL_TRIALS research · 2011-01-28Clinical Trial Update: Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease [Phase 1, Phase 2]
A clinical trial update describes a Phase 1/Phase 2 study of a novel oral zinc cysteine preparation for Alzheimer's disease and mild cogniti…
-
CLINICAL_TRIALS trial_result · 2011-01-26Clinical Trial Update: AD01 Follow up Extension Visit
Follow-up extension visit update for the AD01 Alzheimer's disease trial; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Drug-Drug Interaction Study With Aricept® (Donepezil) [Phase 1]
This Phase 1 trial evaluated potential drug-drug interactions with Aricept (donepezil) in Alzheimer's disease and has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole [Phase 1]
Phase 1 trial update reporting potential drug–drug interactions between the study drug and antifungal agents ketoconazole or fluconazole in …
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER) [Phase 1]
A phase 1 trial evaluated the drug-drug interaction between BMS-708163 and galantamine ER and its effect on pharmacokinetics in Alzheimer's …
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Drug-Drug Interaction Study With Rifampin [Phase 1]
Phase 1 drug-drug interaction study with rifampin in Alzheimer's disease has been completed, sponsored by Bristol-Myers Squibb.